Position in LH
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$582,120
-$83,837 QoQ
Shares Held
2,079
-16.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#551
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NORDEN GROUP LLC holds $3,533,170 across 7 Diagnostics & Research names. LH ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
2,361 | $1,242,924 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,257 | $630,209 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
2,079 | $582,120 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
824 | $436,382 | |
| 5 | GH |
Guardant Health, Inc.
|
2,505 | $375,825 | |
| 6 | DHR |
Danaher Corp /De/
|
1,081 | $205,908 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
2,788 | $59,802 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $582,120 | 2,079 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $665,957 | 2,496 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $676,372 | 2,696 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $777,932 | 2,710 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $917,472 | 3,495 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $805,745 | 3,462 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $723,275 | 3,154 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $582,388 | 2,606 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||